Atrial fibrillation and ischemic events with rivaroxaban in patients with stable coronary artery disease (AFIRE): Protocol for a multicenter, prospective, randomized, open-label, parallel group study

This study will be the first to assess the efficacy and safety of rivaroxaban monotherapy in NVAF patients with stable CAD.